Related Experiment Video

Updated: Nov 8, 2025

Transaxillary First Rib Resection for Treatment of the Thoracic Outlet Syndrome
06:57

Transaxillary First Rib Resection for Treatment of the Thoracic Outlet Syndrome

Published on: September 13, 2020

3.5K

Contemporary treatment of May-Thurner Syndrome

Arash Fereydooni1, Jordan R Stern2

  • 1Division of Vascular and Endovascular Surgery, Department of Surgery, Stanford University Medical Center, Stanford, CA, USA.

The Journal of Cardiovascular Surgery
|April 19, 2021
PubMed

Insights

May-Thurner Syndrome, caused by left iliac vein compression, can lead to leg swelling or deep vein thrombosis. Iliocaval stenting is a standard treatment with good outcomes.

Area of Science:

  • Vascular Surgery
  • Diagnostic Imaging
  • Venous Disease Management

Background:

  • May-Thurner Syndrome arises from left common iliac vein compression by the right common iliac artery.
  • This compression can cause venous outflow obstruction, leading to unilateral leg swelling or deep vein thrombosis.

Purpose of the Study:

  • To review the pathophysiology of May-Thurner Syndrome.
  • To discuss diagnostic modalities and treatment options for May-Thurner Syndrome.

Main Methods:

  • Review of existing literature on May-Thurner Syndrome.
  • Analysis of diagnostic techniques including ultrasound, CT venography, MR venography, and intravascular ultrasound.
  • Evaluation of treatment strategies, focusing on iliac vein stenting.

Main Results:

  • May-Thurner Syndrome diagnosis relies on clinical presentation and imaging.
  • Venography with intravascular ultrasound is optimal for assessing iliac vein compression severity.
  • Iliocaval stenting demonstrates promising patency rates and clinical outcomes for treatment.

Conclusions:

  • Understanding May-Thurner Syndrome's pathophysiology is crucial for diagnosis and management.
  • A combination of diagnostic tools aids in identifying and assessing the severity of venous compression.
  • Iliocaval stenting is an effective, standard treatment for hemodynamically significant May-Thurner Syndrome.

More Related Videos

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm04:56

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

292
Novel and Innovative Hybrid Technique for Type A Aortic Dissection06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

589

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
76
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
96
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
86
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
133
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
105
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
111